Close Menu

NEW YORK (GenomeWeb) ― New Zealand startup Ubiquitome and custom oligo supplier Integrated DNA Technologies (IDT) announced a new partnership today to develop a hand-held Ebola assay.

The assay will be developed by IDT using the firm's PrimeTime qPCR Assay components. It will run on Ubiquitome's hand-held PCR platform, the Freedom4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.